BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22995301)

  • 1. Poly(propylene imine) dendrimers modified with maltose or maltotriose protect phosphorothioate oligodeoxynucleotides against nuclease activity.
    Drzewińska J; Appelhans D; Voit B; Bryszewska M; Klajnert B
    Biochem Biophys Res Commun; 2012 Oct; 427(1):197-201. PubMed ID: 22995301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly organized self-assembled dendriplexes based on poly(propylene imine) glycodendrimer and anti-HIV oligodeoxynucleotides.
    Maly J; Pedziwiatr-Werbicka E; Maly M; Semeradtova A; Appelhans D; Danani A; Zaborski M; Klajnert B; Bryszewska M
    Curr Med Chem; 2012; 19(27):4708-19. PubMed ID: 22834818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of dendriplexes formed by anti-HIV genetic material and poly(propylene imine) dendrimers in the presence of glucosaminoglycans.
    Szewczyk M; Drzewinska J; Dzmitruk V; Shcharbin D; Klajnert B; Appelhans D; Bryszewska M
    J Phys Chem B; 2012 Dec; 116(50):14525-32. PubMed ID: 23199071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of complexes formed by polypropylene imine dendrimers and anti-HIV oligonucleotides.
    Pedziwiatr-Werbicka E; Ferenc M; Zaborski M; Gabara B; Klajnert B; Bryszewska M
    Colloids Surf B Biointerfaces; 2011 Apr; 83(2):360-6. PubMed ID: 21190815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.
    Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Voit B; Szewczyk M; Góra-Tybor J; Robak T; Klajnert B; Bryszewska M
    Mol Pharm; 2013 Jun; 10(6):2490-501. PubMed ID: 23641871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
    Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
    Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates.
    Szulc A; Signorelli M; Schiraldi A; Appelhans D; Voit B; Bryszewska M; Klajnert-Maculewicz B; Fessas D
    Int J Pharm; 2015 Nov; 495(2):940-7. PubMed ID: 26456295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity of poly(propylene imine) dendrimers.
    Ziemba B; Matuszko G; Appelhans D; Voit B; Bryszewska M; Klajnert B
    Biopolymers; 2012 Aug; 97(8):642-8. PubMed ID: 22605555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stability.
    Ciolkowski M; Pałecz B; Appelhans D; Voit B; Klajnert B; Bryszewska M
    Colloids Surf B Biointerfaces; 2012 Jun; 95():103-8. PubMed ID: 22410344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of fourth generation poly(propyleneimine) dendrimers on blood cells.
    Ziemba B; Halets I; Shcharbin D; Appelhans D; Voit B; Pieszynski I; Bryszewska M; Klajnert B
    J Biomed Mater Res A; 2012 Nov; 100(11):2870-80. PubMed ID: 22623362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dense shell glycodendrimers as potential nontoxic anti-amyloidogenic agents in Alzheimer's disease. Amyloid-dendrimer aggregates morphology and cell toxicity.
    Klementieva O; Benseny-Cases N; Gella A; Appelhans D; Voit B; Cladera J
    Biomacromolecules; 2011 Nov; 12(11):3903-9. PubMed ID: 21936579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction study between maltose-modified PPI dendrimers and lipidic model membranes.
    Wrobel D; Appelhans D; Signorelli M; Wiesner B; Fessas D; Scheler U; Voit B; Maly J
    Biochim Biophys Acta; 2015 Jul; 1848(7):1490-501. PubMed ID: 25843678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease.
    Klementieva O; Aso E; Filippini D; Benseny-Cases N; Carmona M; Juvés S; Appelhans D; Cladera J; Ferrer I
    Biomacromolecules; 2013 Oct; 14(10):3570-80. PubMed ID: 24004423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gd-Chelated poly(propylene imine) dendrimers with densely organized maltose shells for enhanced MR imaging applications.
    Xiong Z; Wang Y; Zhu J; He Y; Qu J; Effenberg C; Xia J; Appelhans D; Shi X
    Biomater Sci; 2016 Oct; 4(11):1622-1629. PubMed ID: 27722500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.
    Franiak-Pietryga I; Ziemba B; Sikorska H; Jander M; Kuncman W; Danilewicz M; Appelhans D; Lewkowicz P; Ostrowska K; Bryszewska M; Borowiec M
    Toxicol Appl Pharmacol; 2020 Sep; 403():115139. PubMed ID: 32687837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance.
    Szulc A; Pulaski L; Appelhans D; Voit B; Klajnert-Maculewicz B
    Int J Pharm; 2016 Nov; 513(1-2):572-583. PubMed ID: 27667754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers.
    Agashe HB; Babbar AK; Jain S; Sharma RK; Mishra AK; Asthana A; Garg M; Dutta T; Jain NK
    Nanomedicine; 2007 Jun; 3(2):120-7. PubMed ID: 17572354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo toxicity of poly(propyleneimine) dendrimers.
    Ziemba B; Janaszewska A; Ciepluch K; Krotewicz M; Fogel WA; Appelhans D; Voit B; Bryszewska M; Klajnert B
    J Biomed Mater Res A; 2011 Nov; 99(2):261-8. PubMed ID: 21976451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of amyloid and prion fibril formation in the absence and presence of dense shell sugar-decorated dendrimers.
    Ottaviani MF; Cangiotti M; Fiorani L; Fattori A; Wasiak T; Appelhans D; Klajnert B
    Curr Med Chem; 2012; 19(34):5907-21. PubMed ID: 22834819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studying complexes between PPI dendrimers and Mant-ATP.
    Szulc A; Appelhans D; Voit B; Bryszewska M; Klajnert B
    J Fluoresc; 2013 Mar; 23(2):349-56. PubMed ID: 23306952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.